These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16160482)

  • 1. Abnormal intrahepatic portal vasculature in native and allograft liver biopsies: a comparative analysis.
    Krasinskas AM; Goldsmith JD; Burke A; Furth EE
    Am J Surg Pathol; 2005 Oct; 29(10):1382-8. PubMed ID: 16160482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C.
    Souza P; Prihoda TJ; Hoyumpa AM; Sharkey FE
    Hum Pathol; 2009 Jan; 40(1):92-7. PubMed ID: 18790517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection.
    Matsumoto Y; McCaughan GW; Painter DM; Bishop GA
    Transplantation; 1993 Jul; 56(1):69-75. PubMed ID: 8333070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis.
    Yeh MM; Larson AM; Tung BY; Swanson PE; Upton MP
    Am J Surg Pathol; 2006 Jun; 30(6):727-33. PubMed ID: 16723850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric inflammatory cell analysis of human liver allograft biopsies.
    Foster PF; Sankary HN; Williams JW; Bhattacharyya A; Coleman J; Ashmann M
    Transplantation; 1991 Apr; 51(4):873-6. PubMed ID: 2014546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Demetris AJ; Seaberg EC; Batts KP; Ferrell L; Lee RG; Markin R; Detre KM
    Am J Surg Pathol; 1998 Jan; 22(1):28-39. PubMed ID: 9422313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury.
    Rosen HR; Gretch DR; Oehlke M; Flora KD; Benner KG; Rabkin JM; Corless CL
    Transplantation; 1998 May; 65(9):1178-82. PubMed ID: 9603164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic progression of recurrent hepatitis C in liver transplant allografts.
    Greenson JK; Svoboda-Newman SM; Merion RM; Frank TS
    Am J Surg Pathol; 1996 Jun; 20(6):731-8. PubMed ID: 8651353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis.
    Guido M; Sarcognato S; Russo FP; Cardin R; Piciocchi M; Colloredo G; Farinati F
    Liver Int; 2018 Oct; 38(10):1770-1776. PubMed ID: 29427537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Banff schema for grading liver allograft rejection: utility in clinical practice.
    Ormonde DG; de Boer WB; Kierath A; Bell R; Shilkin KB; House AK; Jeffrey GP; Reed WD
    Liver Transpl Surg; 1999 Jul; 5(4):261-8. PubMed ID: 10388498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients.
    Londoño MC; Souza LN; Lozano JJ; Miquel R; Abraldes JG; Llovet LP; Quaglia A; Rimola A; Navasa M; Sánchez-Fueyo A
    J Hepatol; 2018 Sep; 69(3):626-634. PubMed ID: 29709679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for portal fibrosis in pediatric liver transplant recipients.
    Peeters PM; Sieders E; vd Heuvel M; Bijleveld CM; de Jong KP; TenVergert EM; Slooff MJ; Gouw AS
    Transplantation; 2000 Dec; 70(11):1581-7. PubMed ID: 11152219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation.
    Conti F; Grude P; Calmus Y; Scoazec JY
    J Hepatol; 1997 Nov; 27(5):881-9. PubMed ID: 9382976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.